Top entities: Intuitive Surgical, Medtronic, Jamie Samath, S&P 500, Nasdaq.

What category does this event fall under?

Business — classified as stock decline.

What is the sentiment of coverage?

Aggregate sentiment score: -30 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

What were the key actions taken?

Intuitive Surgical saw stock decline · Intuitive Surgical topped estimates · Intuitive Surgical reported procedure growth

Is this event still developing?

This is an active story, last updated Jul 21, 2026. Coverage continues to evolve.

Business stock decline

Intuitive Surgical stock down 38% in 2026

Q: When did this event occur?

First reported Jul 17, 2026; last updated Jul 21, 2026.

Q: What is the market impact?

General. Intuitive Surgical's stock decline reflects market concerns about slowing growth and valuation compression, but the company's strong fundamentals and expanding install base may limit downside.

Analysis based on 6 articles · First reported Jul 17, 2026 · Last updated Jul 21, 2026

Sentiment

-30

Attention

Articles

Market Impact

General

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

Intuitive Surgical's stock decline reflects market concerns about slowing growth and valuation compression, but the company's strong fundamentals and expanding install base may limit downside. The broader medical device sector could see mixed sentiment as investors weigh growth prospects against competitive pressures.

Healthcare Medical Devices

Event Summary

Intuitive Surgical, maker of the da Vinci robotic-assisted surgical systems, has seen its stock decline approximately 38% in 2026, reaching multi-year lows. The decline follows a strong second quarter with revenue of $2.9 billion (up 19% year-over-year) and procedure growth of 15%. However, headwinds include the expiration of Affordable Care Act enhanced premiums, a decline in bariatric cases due to GLP-1 weight loss drugs, and a slowdown in procedure growth guidance (13%-15% for 2026 vs 18% in 2025). The stock's P/E ratio has fallen from 95x in early 2025 to around 33x-47x, making it relatively cheaper compared to its historical average of 68x. Analysts suggest the sell-off may present a buying opportunity for long-term investors, though competition from Medtronic and other players remains a concern.

Key Actions

90 Intuitive Surgical saw stock decline

80 Intuitive Surgical topped estimates

50 Intuitive Surgical reported procedure growth

40 Jamie Samath noted ACA impact Intuitive Surgical

Entities Involved

stock

Intuitive Surgical

Intuitive Surgical is the central entity; its stock has fallen 38% in 2026 despite strong Q2 results, due to valuation compression and headwinds from ACA expiration and GLP-1 drugs.

Importance 100.0 Sentiment -30.0

stock

Medtronic

Medtronic is mentioned as a competitor in surgical robotics, but no specific actions or impacts are detailed.

Importance 20.0 Sentiment 0.0

per

Jamie Samath

Jamie Samath, CFO of Intuitive Surgical, noted the modest adverse impact of ACA enhanced premium expiration on procedures, contributing to market apprehension.

Importance 15.0 Sentiment -10.0

index

S&P 500

The S&P 500 index is used as a benchmark for valuation comparison; Intuitive Surgical's P/E remains above the S&P 500 average of 27.5x.

Importance 10.0 Sentiment 0.0

exch

Nasdaq

Nasdaq is the exchange where Intuitive Surgical is listed; no direct impact from the event.

Importance 5.0 Sentiment 0.0

Relationships

Intuitive Surgical related ↔ Medtronic

S&P 500 related ↔ Nasdaq

ERGEN INTELLIGENCE

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard